Loading...
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
Gene therapy using recombinant adeno‐associated virus (rAAV) vectors to treat blinding retinal dystrophies has become clinical reality. Therapeutically impactful targeting of photoreceptors still relies on subretinal vector delivery, which detaches the retina and harbours substantial risks of collat...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033523/ https://ncbi.nlm.nih.gov/pubmed/33616280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013392 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|